Expleo Solutions Balance Sheet Health
Financial Health criteria checks 6/6
Expleo Solutions has a total shareholder equity of ₹6.7B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹8.8B and ₹2.0B respectively. Expleo Solutions's EBIT is ₹1.3B making its interest coverage ratio -32.5. It has cash and short-term investments of ₹2.8B.
Key information
0%
Debt to equity ratio
₹0
Debt
Interest coverage ratio | -32.5x |
Cash | ₹2.76b |
Equity | ₹6.71b |
Total liabilities | ₹2.05b |
Total assets | ₹8.76b |
Recent financial health updates
No updates
Recent updates
Further Upside For Expleo Solutions Limited (NSE:EXPLEOSOL) Shares Could Introduce Price Risks After 25% Bounce
Dec 18Expleo Solutions' (NSE:EXPLEOSOL) Conservative Accounting Might Explain Soft Earnings
Nov 22Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 24When Should You Buy Expleo Solutions Limited (NSE:EXPLEOSOL)?
Jun 21Investors Could Be Concerned With Expleo Solutions' (NSE:EXPLEOSOL) Returns On Capital
Mar 15The Returns On Capital At Expleo Solutions (NSE:EXPLEOSOL) Don't Inspire Confidence
Sep 15Increases to Expleo Solutions Limited's (NSE:EXPLEOSOL) CEO Compensation Might Cool off for now
Aug 19Calculating The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Jul 14Many Would Be Envious Of Expleo Solutions' (NSE:EXPLEOSOL) Excellent Returns On Capital
May 05A Look At The Fair Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Mar 15Expleo Solutions Limited's (NSE:EXPLEOSOL) Stock Been Rising: Are Strong Financials Guiding The Market?
Feb 15Expleo Solutions (NSE:EXPLEOSOL) Knows How to Allocate Capital
Jan 24Introducing Expleo Solutions (NSE:EXPLEOSOL), A Stock That Climbed 76% In The Last Year
Jan 04A Look At The Intrinsic Value Of Expleo Solutions Limited (NSE:EXPLEOSOL)
Dec 14Is There More To The Story Than Expleo Solutions's (NSE:EXPLEOSOL) Earnings Growth?
Nov 26Financial Position Analysis
Short Term Liabilities: EXPLEOSOL's short term assets (₹7.0B) exceed its short term liabilities (₹1.5B).
Long Term Liabilities: EXPLEOSOL's short term assets (₹7.0B) exceed its long term liabilities (₹590.0M).
Debt to Equity History and Analysis
Debt Level: EXPLEOSOL is debt free.
Reducing Debt: EXPLEOSOL had no debt 5 years ago.
Debt Coverage: EXPLEOSOL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EXPLEOSOL has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 03:42 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Expleo Solutions Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Anil Burra | FirstCall Research |
Naveed MD. | FirstCall Research |
Abhay Moghe | IL&FS Broking Services Private Limited |